TELADOC HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.01 USD | -2.40% |
|
+0.23% | -39.63% |
| Apr. 26 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
| Apr. 26 | Oppenheimer Cuts Teladoc's Price Target to $21 From $26, Maintains Outperform Rating | MT |
Chart calendar Teladoc Health, Inc.
aaa5e15419103.LH7dz98Xl1ys1Aj7JafCfCHXQ7CKuJ266Do0Gvnkob0.FDWtjJMv5gnOjCXWdJCURBaWMIjdiKjAol8FW46lwtRCBJH-m0LzGeWAaw~5fb63b267db2a5bdd2713bc54b6ea454
Upcoming events on Teladoc Health, Inc.
Past events on Teladoc Health, Inc.
| 2024-04-25 05:00 pm | Q1 2024 Earnings Call |
| 2024-04-25 04:05 pm | Q1 2024 Earnings Release |
| 2024-03-13 09:30 am | Barclays Global Healthcare Conference |
| 2024-03-04 02:50 pm | TD Cowen Health Care Conference |
| 2024-02-20 05:00 pm | Q4 2023 Earnings Call |
| 2024-02-20 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-09 04:30 pm | JPMorgan Healthcare Conference |
| 2023-11-28 12:00 pm | Piper Sandler Healthcare Conference |
| 2023-10-24 04:30 pm | Q3 2023 Earnings Call |
| 2023-10-24 04:05 pm | Q3 2023 Earnings Release |
| 2023-08-09 10:00 am | Canaccord Genuity Growth Conference |
| 2023-07-25 04:30 pm | Q2 2023 Earnings Call |
| 2023-07-25 04:05 pm | Q2 2023 Earnings Release |
| 2023-05-25 02:00 pm | Annual General Meeting |
| 2023-04-26 04:30 pm | Q1 2023 Earnings Call |
| 2023-04-26 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-06 12:50 pm | TD Cowen Health Care Conference |
| 2023-02-22 04:30 pm | FY 2022 Earnings Call |
| 2023-02-22 04:05 pm | FY 2022 Earnings Release |
| 2023-01-09 12:00 pm | JP Morgan Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 553 550 0.59% | 1 094 1 105 -0.97% | 2 033 2 026 0.34% | 2 407 2 402 0.18% | 2 602 2 613 -0.4% | 2 665 |
|
EBITDA Million USD | Released Forecast Spread | 31,8 30,3 5.16% | 127 116 9.46% | 268 262 2.12% | 247 243 1.25% | 328 325 0.82% | 366 |
|
EBIT Million USD | Released Forecast Spread | -80,4 -81,3 1.01% | -506 -67,0 -656.34% | -266 -292 9.12% | -13 653 -9 872 -38.3% | -249 -254 2.27% | -224 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -109 -110 0.79% | -576 -124 -363.91% | -385 -406 5.2% | -13 663 -9 891 -38.14% | -220 -231 4.83% | -179 |
|
Net income Million USD | Released Forecast Spread | -98,9 -104 4.53% | -485 -125 -288.75% | -429 -495 13.46% | -13 660 -9 890 -38.12% | -220 -228 3.52% | -171 |
|
EPS USD | Released Forecast Spread | -1,38 -1,44 4.34% | -5,36 -1,35 -296.02% | -2,73 -3,26 16.17% | -84,6 -61,3 -38.08% | -1,34 -1,42 5.31% | -1,05 |
| Announcement Date | 26/02/20 | 24/02/21 | 22/02/22 | 22/02/23 | 20/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 554 546 1.42% | 565 569 -0.58% | 592 587 0.87% | 611 609 0.4% | 638 633 0.68% | 629 618 1.78% | 652 649 0.5% | 660 663 -0.43% | 661 671 -1.57% | 646 639 1.11% | 657 | 676 | 689 | 673 |
|
EBITDA Million USD | Released Forecast Spread | 77,1 72,1 6.97% | 54,5 53,0 2.8% | 46,7 44,9 4.09% | 51,2 40,2 27.24% | 94,1 91,8 2.44% | 52,8 46,0 14.66% | 72,2 64,5 11.9% | 88,8 76,4 16.14% | 114 112 2.36% | 63,1 57,7 9.47% | 79,1 | 97,5 | 129 | 80,8 |
|
EBIT Million USD | Released Forecast Spread | -41,4 -66,5 37.75% | -6 669 -76,8 -8581.69% | -3 097 -85,4 -3525.08% | -71,7 -79,6 9.88% | -3 816 -32,1 -11797.82% | -77,1 -79,3 2.73% | -71,6 -67,6 -5.91% | -64,7 -63,1 -2.64% | -35,1 -44,4 21.03% | -87,1 -85,2 -2.26% | -70,3 | -42,7 | -23,8 | -60,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -60,7 -84,4 28.05% | -6 674 -94,7 -6950.79% | -3 103 -98,0 -3064.65% | -74,6 -91,1 18.1% | -3 812 -37,6 -10026.59% | -68,5 -80,2 14.53% | -66,1 -65,9 -0.4% | -59,6 -58,5 -1.82% | -25,4 -39,5 35.71% | -79,2 -76,4 -3.71% | -59,7 | -37,7 | -2,95 | -53,7 |
|
Net income Million USD | Released Forecast Spread | -11,0 -89,6 87.73% | -6 675 -90,5 -7277.76% | -3 101 -103 -2906.38% | -73,5 -91,4 19.64% | -3 810 -35,4 -10658.71% | -69,2 -81,0 14.59% | -65,2 -67,8 3.87% | -57,1 -61,2 6.81% | -28,9 -39,2 26.31% | -81,9 -77,8 -5.25% | -53,8 | -33,7 | -0,26 | -55,8 |
|
EPS USD | Released Forecast Spread | -0,07 -0,58 87.95% | -41,6 -0,56 -7265.29% | -19,2 -0,64 -2883.96% | -0,45 -0,57 20.64% | -23,5 -0,23 -10212.13% | -0,42 -0,50 15.62% | -0,40 -0,40 0.51% | -0,35 -0,37 5.11% | -0,17 -0,24 30.36% | -0,49 -0,47 -3.9% | -0,33 | -0,22 | -0,03 | -0,29 |
| Announcement Date | 22/02/22 | 27/04/22 | 27/07/22 | 26/10/22 | 22/02/23 | 26/04/23 | 25/07/23 | 24/10/23 | 20/02/24 | 25/04/24 | - | - | - | - |
More events
Past sector events for Teladoc Health, Inc.
| 2024-04-25 04:05 pm | TELADOC HEALTH, INC.: Q1 2024 Earnings Release |
| 2024-02-26 04:05 pm | HIMS & HERS HEALTH, INC.: Q4 2023 Earnings Release |
| 2024-02-22 08:00 am | TALKSPACE, INC.: Q4 2023 Earnings Release |
| 2024-02-20 04:05 pm | TELADOC HEALTH, INC.: Q4 2023 Earnings Release |
| 2023-11-06 04:05 pm | HIMS & HERS HEALTH, INC.: Q3 2023 Earnings Release |
| 2023-10-24 04:05 pm | TELADOC HEALTH, INC.: Q3 2023 Earnings Release |
| 2023-08-07 04:15 pm | HIMS & HERS HEALTH, INC.: Q2 2023 Earnings Release |
| 2023-07-25 04:05 pm | TELADOC HEALTH, INC.: Q2 2023 Earnings Release |
| 2023-05-08 04:15 pm | HIMS & HERS HEALTH, INC.: Q1 2023 Earnings Release |
| 2023-04-26 04:05 pm | TELADOC HEALTH, INC.: Q1 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TDOC Stock
- Calendar Teladoc Health, Inc.
